HomeNewsScreenerChartsMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

New Elite Feature: Chart Templates — Your indicators and design everywhere on Finviz

Learn More
Market News Market Pulse Stocks News ETF News Crypto News

Dyadic International, Inc.

Contributing Author

Recent Articles by Dyadic International, Inc.

Mar-25
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress DYAI -19.63% DYAI GlobeNewswire
Mar-16
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices DYAI +6.50% GlobeNewswire
Mar-11
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 DYAI GlobeNewswire
Mar-04
Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free) DYAI GlobeNewswire
Mar-02
Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone DYAI GlobeNewswire
Feb-17
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin DYAI GlobeNewswire
Dec-17
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets DYAI GlobeNewswire
Dec-15
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic's Recombinant Growth Factors and Media Proteins DYAI -9.25% GlobeNewswire
Dec-01
Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets DYAI GlobeNewswire
Nov-12
Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress DYAI GlobeNewswire
Nov-10
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics DYAI +6.91% GlobeNewswire
Oct-29
Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025 DYAI GlobeNewswire
Oct-06
Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments DYAI GlobeNewswire
Sep-04
Dyadic to Present at Investor Conferences and BPI East DYAI GlobeNewswire
Aug-13
Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress DYAI GlobeNewswire
Aug-05
Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025 DYAI GlobeNewswire
Jul-31
UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock DYAI -6.19% GlobeNewswire
Jul-31
Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock DYAI -6.19% GlobeNewswire
Jul-30
Dyadic International, Inc. Announces Proposed Public Offering of Common Stock DYAI GlobeNewswire
Jun-02
Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications DYAI GlobeNewswire
May-14
Dyadic Reports First Quarter 2025 Financial Results and Highlights of Recent Company Progress DYAI GlobeNewswire
May-01
Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 DYAI GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)